
AMD Package 4G (4-5 month supply)
Special Price
$979.20
Regular Price
$1,088.01
Targets retinal health, blood vessel support and reducing unwanted growth of new blood vessels.
AvailabilityIn stock
SKU
AMD-4G
AMD Package 4G (3-month supply) – this package is designed to support the health of the retina, strengthen blood vessels and circulation, and help prevent the growth of new (unwanted) blood vessels.
Package content includes:
- Advanced Eye and Vision Support formula - 3 bottles - whole food, organic eye formula for retinal and overall eye health.
- Dr. Grossman's Meso Plus Formula with Astaxanthin 90 vcaps - 1 bottle - with mesozeaxanthin found to be essential for supporting central vision as well as astaxanthin.
- Dr. Grossman's Whole Food Superfood Multi-Vitamin 120 Vcaps - 3 bottles
- OmegaGenics EPA / DHA 3 bottles, 5 fl. oz. - for retinal and overall body health.
- Vitamin D3 2000 IU 90 vcaps 1 bottle - for retinal and overall body support.
- Resveratrol (Trans) w/Quercetin 60 vegcaps - Antioxidant 3 bottles - helps strengthen blood vessels and is a powerful antioxidant.
- Dr. Grossman’s Blood Vessel Control Formula 3 bottles - combination of herbs based on NIH Study that help prevent the growth of new (unwanted) blood vessels. ON BACKORDER - see instead Relaxed Wanderer 120 tabs which the Revision was based on. based on classic Liver tonic used in Classic Chinese patent formula for promoting the free flow of energy and circulation throughout the eyes and body
- Dr. Grossman’s Bilberry/Ginkgo Combination 2oz (60ml) 3 bottles - helps strengthen blood vessels and support healthy circulation to the retina
- Taurine - 1 bottle
- Melatonin (50) MZS 60 x 3mg Tabs -1 box
- Retinal Support (wild-crafted herbal formula) 2 oz 3 bottles – based on classic Chinese medical approach for nourishing the retinal and overall body support.
- Nitric Oxide Supplement - 3 bottles - Anti-vascular endothelial growth factor (VEGF) therapy has been shown to disrupt the normal nitric oxide signaling pathway, producing systemic arterial hypertension following systemically administered anti-VEGF in oncology by exactly that mechanism.
* J Ocul Pharmacol Ther. 2015 Feb;31(1):2-10. doi: 10.1089/jop.2014.0062.
Free 1st Class Shipping | Free 1st Class Shipping |
---|
Write Your Own Review